Form 4: SANUWAVE Health Executive Cioanta Reports Stock Transactions

Iulian Cioanta, Chief Science and Technology Officer of SANUWAVE Health, Inc., reports multiple transactions involving common stock and stock options on May 15, 2025.

Summary

• On May 15, 2025, Iulian Cioanta, the Chief Science and Technology Officer of SANUWAVE Health, Inc., engaged in several transactions involving the company's stock.
• These transactions included the exercise of stock options at prices of $14.2, $22.5, and $15, resulting in the acquisition of 1,777, 529, and 1,333 shares of common stock, respectively.
• Additionally, Cioanta disposed of 3,639 shares of common stock at a price of $31.6.
• Following these transactions, Cioanta directly owns 41 shares of common stock and holds options for 8,890 shares at an exercise price of $14.2.
• Some options vest quarterly from October 22, 2024, over three years, while others are fully vested.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.

Industry Context

This is a standard SEC Form 4 filing, which is a routine part of corporate governance and transparency, providing insight into the trading activities of company insiders. It is common for executives to exercise stock options and sell shares, and the details are publicly disclosed to maintain market integrity.

Comparison to Industry Standards

• Form 4 filings are standard practice across all publicly traded companies in the US, including SANUWAVE Health's competitors.
• The reported transactions are similar to those seen by executives at comparable companies such as Medtronic or Boston Scientific, where stock options are part of compensation packages.
• The filing adheres to SEC regulations, ensuring transparency in insider trading activities, a benchmark for corporate governance.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider trading activities.
• It helps maintain market confidence by ensuring that executives are not engaging in undisclosed or unfair trading practices.

Key Dates

Keywords

SANUWAVE Health, Stock Options, Form 4, Insider Trading, Iulian Cioanta, SNWV, Securities Transactions